Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the efficacy, safety and pharmacokinetics of ONO-5129 in patients with type 2 diabetes mellitus.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ono Pharma USA Inc

Criteria

Inclusion Criteria:

1. Fasting Blood Glucose 126-250mg/dL

2. HbA1c 6.5-11%

Exclusion Criteria:

1. Previous treatment with antidiabetic agents equal to or less than 2-3 months prior to randomization

2. History of myocardial infarction, coronary artery surgery

3. Other eligibility criteria as specified in the study protocol